SANUWAVE’S PACE Shows Promise In Stimulating Autogenous Sources Of Progenitor/STEM Cells For Harvest And Re-Transplantation In Bone Tissue Engineering


Share to Facebook Share to Twitter Stumble It Email This More...

SANUWAVE Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, reported that scientific findings titled “Extracorporeal Shock Wave Stimulation of Osteoprogenitor Cells” were presented at the 2009 International Bone-Tissue-Engineering Congress (“Bone-Tec”) in Hannover, Germany, which was held October 9-11, 2009.

Dr. Myron Spector, PhD, Professor of Orthopaedic Surgery (Biomaterials) at Harvard Medical School, Director of Orthopaedic Research at Brigham and Women’s Hospital and Director of Tissue Engineering at VA Boston Healthcare System, was an invited guest speaker at the Conference. The Bone–Tec Congress featured an international scientific forum to discuss progresses in modern bone tissue regeneration and extended a worldwide network to exchange findings on the latest developments.

Dr. Spector’s team employed SANUWAVE’s Pulsed Acoustic Cellular Expression (PACE™) technology in preclinical research to create autogenous sources of stem cells for bone tissue engineering. Results support the proposition that PACE™ could be employed as a non-invasive technique to cause proliferation and thickening of the cambium layer of the femur’s periosteum for the subsequent intraoperative harvesting of progenitor stem cells days later for bone or cartilage regeneration.

PACE™ stimulated a dramatic proliferation and thickening (up to 10 fold) of osteoprogenitor stem cells, precursors to bone and cartilage cells, in the cambium layer of the periosteum in the femur of the adult rats within 4 days. Neovascularization and new bone formation within the thickened periosteum were also evident after 4 days.

Dr. Spector said, “This research has shown great potential. Through more study, this technology could further advance tissue engineering autologous transplant techniques towards clinical applications such as bone reconstruction and cartilage defect repair.” (…)

from http://www.sanuwave.com

Reblog this post [with Zemanta]

Maybe you can find something interesting in the following sponsored links:


Share to Facebook Share to Twitter Stumble It Email This More...
Related pages on the web
  • The Chevy Volt Rising gas prices and a worry about dependence on foreign oil has led car companies to completely change their strategy. These companies must now focus on electric vehicles, working to find renewable energy resources that are going to pull cars...
  • Find Advice About Search Engine Optimization You may be asking what are the benefits of Website optimization Techniques?, do I need to make use of Search engine optimization to advertise my website? how do I know it works? is it worth the effort? In the next...
  • Cord Blood Donation As I have mentioned before, there is a ton to think about before having a baby. These days with so much information out there, it's hard NOT to over think things. Especially when you are me. You even find yourself...
  • Black Hat Vs White Hat SEO There is a divide in the SEO community when it comes to the colour of the hat that you wear, and there is much debate on what separates black hat from white hat Search Engine Optimisation techniques. So what is...
  • All You Need For An Website Business As Well As Re-Sell Rights New to the Internet marketing and advertising? Then you want this economical package that provides you NINE different programs. I have set out the FIRST program in the outline below. Imagine, if you will, what eight more of these programs...
Blog Traffic Exchange Related articles on this site

1 Responses to “SANUWAVE’S PACE Shows Promise In Stimulating Autogenous Sources Of Progenitor/STEM Cells For Harvest And Re-Transplantation In Bone Tissue Engineering”


  1. No Comments
  1. 1 Stem Cells Used to Create New Jaw Bone « Stem Cell News

Leave a Reply